Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock
-
Shares outstanding
-
24.7M
-
Number of holders
-
239
-
Total 13F shares, excl. options
-
22.3M
-
Shares change
-
+236K
-
Total reported value, excl. options
-
$3.51B
-
Value change
-
+$39.6M
-
Put/Call ratio
-
4.98
-
Number of buys
-
106
-
Number of sells
-
-111
-
Price
-
$157.48
Significant Holders of ICU MEDICAL INC/DE - Common Stock (ICUI) as of Q4 2022
275 filings reported holding ICUI - ICU MEDICAL INC/DE - Common Stock as of Q4 2022.
ICU MEDICAL INC/DE - Common Stock (ICUI) has 239 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 22.3M shares
of 24.7M outstanding shares and own 90.25% of the company stock.
Largest 10 shareholders include JANUS HENDERSON GROUP PLC (2.56M shares), T. Rowe Price Investment Management, Inc. (2.42M shares), WELLINGTON MANAGEMENT GROUP LLP (2.37M shares), VANGUARD GROUP INC (2.1M shares), BlackRock Inc. (1.79M shares), NUANCE INVESTMENTS, LLC (939K shares), JPMORGAN CHASE & CO (754K shares), MORGAN STANLEY (680K shares), STATE STREET CORP (594K shares), and FULLER & THALER ASSET MANAGEMENT, INC. (579K shares).
This table shows the top 239 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.